bioRxivCancer Biology
Netrin signaling mediates survival of dormant epithelial ovarian cancer cells
P. Perampalam, J. I. MacDonald, K. Zakirova, D. Passos, S. Wasif, Y. Ramos-Valdes, M. Hervieu, P. Mehlen, R. Rottapel, B. Gibert, R. Correa, T. Shepherd, F. Dick
Abstract
Dormancy in cancer is a clinical state in which residual disease remains undetectable for a prolonged duration. At a cellular level, rare cancer cells cease proliferation and survive chemotherapy and disseminate disease. We created a suspension culture model of high grade serous ovarian cancer (HGSOC) dormancy and devised a novel CRISPR screening approach to identify survival genes in this context. In combination with RNA-seq, we discovered the Netrin signaling pathway as critical to dormant HGSOC cell survival. We demonstrate that Netrin-1, -3, and its receptors are essential for low level ERK activation to promote survival, and that Netrin activation of ERK is unable to induce proliferation. Deletion of all UNC5 family receptors blocks Netrin signaling in HGSOC cells and compromises viability during the dormancy step of dissemination in xenograft assays. Furthermore, we demonstrate that Netrin-1 and -3 overexpression in HGSOC correlates with poor outcome. Specifically, our experiments reveal that Netrin overexpression elevates cell survival in dormant culture conditions and contributes to greater spread of disease in a xenograft model of abdominal dissemination. This study highlights Netrin signaling as a key mediator HGSOC cancer cell dormancy and metastasis.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- WNT8B and -9B promote the survival and dissemination of dormant ovarian cancer cells
Komila Zakirova, Daniel T. Passos, … Frederick A. Dick·bioRxiv·Aug 11, 2026
- Eliciting OTUD3/RIPK-Dependent Necroptosis to Prevent Epithelial Ovarian Cancer
J. Johnson, E. C. Bales, … Z. L. Watson·bioRxiv·Apr 29, 2020
- Inducible re-epithelialization of cancer cells increases autophagy and DNA damage: implications for breast cancer dormancy
Diana Drago Garcia, Suvendu Giri, … Yosef Yarden·bioRxiv·Feb 9, 2025
- High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils
Alexander Emmanuelli, Camilla Salvagno, … Juan R. Cubillos‐Ruiz·OncoImmunologyPeer-reviewed·Oct 2, 2024
- IRAK1 is a critical mediator of low molecular weight hyaluronic acid-induced stemness in high-grade serous ovarian cancer
D. Standing, P. Dandawate, … S. Anant·bioRxiv·Sep 25, 2023
- A specific agonist of the orphan nuclear receptor NR2F1 suppresses metastasis through the induction of cancer cell dormancy
B. D. Khalil, R. Sanchez, … J. A. Aguirre-Ghiso·bioRxiv·Jan 30, 2021